Figure 2
From: Sorafenib in advanced melanoma: a critical role for pharmacokinetics?
Effect of dose escalation on intra patient sorafenib AUC (mg l−1 h−1). Median AUCs from 19 patients are represented. In red: increased exposure; in orange: stable exposure; in green: decreased exposure.
